OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
OxThera has raised €74M across 4 funding rounds from 6 investors, most recently a round in Nov 2016. Based in Stockholm, Sweden; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2016-11-01 | Other | €32M | Industrifonden,LSP,Sunstone Capital,Ysios Capital | View deal → |
| 2014-04-01 | Other | €7.7M | IDInvest Partners | View deal → |
| 2007-06-01 | Other | €17M | HealthCap | View deal → |
| 2005-07-01 | Other | €18M | HealthCap | View deal → |
